Cargando…

Dental problems delaying the initiation of interferon therapy for HCV-infected patients

BACKGROUND: There has been little discussion about the importance of oral management and interferon (IFN) therapy, although management of the side effects of therapy for chronic hepatitis C has been documented. This study determined whether dental problems delayed the initiation of IFN therapy for h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Yumiko, Sata, Michio
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933590/ https://www.ncbi.nlm.nih.gov/pubmed/20712912 http://dx.doi.org/10.1186/1743-422X-7-192

Ejemplares similares

Analysis of the factors motivating HCV-infected patients to accept interferon therapy
por: Nagao, Yumiko, et al.
Publicado: (2012)

Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases
por: Nagao, Yumiko, et al.
Publicado: (2012)

Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
por: Nagao, Yumiko, et al.
Publicado: (2010)

Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection
por: Nagao, Yumiko, et al.
Publicado: (2011)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study
por: Nagao, Yumiko, et al.
Publicado: (2012)

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals
por: Nagao, Yumiko, et al.
Publicado: (2016)

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia
por: Kawaguchi, Takumi, et al.
Publicado: (2019)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients
por: Yamasaki, Kazumi, et al.
Publicado: (2012)

A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus
por: Nagao, Yumiko, et al.
Publicado: (2012)

Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman
por: Nagao, Yumiko, et al.
Publicado: (2014)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
por: Toyoda, Hidenori, et al.
Publicado: (2012)

Effect of Oral Care Gel for Burning Mouth Syndrome in a Patient with Hepatitis C: A Case Report
por: Nagao, Yumiko, et al.
Publicado: (2017)

Altered Thymic Function during Interferon Therapy in HCV-Infected Patients
por: Beq, Stephanie, et al.
Publicado: (2012)

Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran
por: Hesamizadeh, Khashayar, et al.
Publicado: (2019)

Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
por: Kleefeld, Felix, et al.
Publicado: (2017)

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection
por: Sumie, Shuji, et al.
Publicado: (2011)

Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report
por: Misaka, Kenji, et al.
Publicado: (2016)

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population
por: Mansoor, Atika, et al.
Publicado: (2013)

Regulation of the Interferon Response by lncRNAs in HCV Infection
por: Valadkhan, Saba, et al.
Publicado: (2018)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
por: Canini, Laetitia, et al.
Publicado: (2017)

Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK)
por: Ahmad, Bashir, et al.
Publicado: (2012)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection
por: Kishida, Yutaka, et al.
Publicado: (2016)

Analysis of hepatitis B and C virus infections amongst members of the Dental National Health Insurance Society in the Oita Prefecture
por: Nagao, Yumiko, et al.
Publicado: (2021)

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
por: Zicca, Emilia, et al.
Publicado: (2014)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders
por: Uemura, Haruka, et al.
Publicado: (2017)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
por: Lin, Chih Ying, et al.
Publicado: (2020)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals
por: Vogel, M, et al.
Publicado: (2010)

Recent advances in the anti-HCV mechanisms of interferon
por: Huang, Menghao, et al.
Publicado: (2014)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
por: Nagao, Yumiko, et al.
Publicado: (2017)

Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients
por: Chen, Hongbo, et al.
Publicado: (2014)

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
por: Hsu, Ching-Sheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7pjosr05vavhrcm5ed3tbmobsp